Paul Matteis
Stock Analyst at Stifel Nicolaus
(4.52)
# 1,065
Out of 5,082 analysts
754
Total ratings
43.9%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Paul Matteis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LBRX LB Pharmaceuticals | Reiterated: Buy | $53 | $39.64 | +33.70% | 5 | Oct 21, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $28 | $8.99 | +211.46% | 14 | Oct 12, 2026 | |
| IMUX Immunic | Reiterated: Buy | $25 | $7.61 | +228.52% | 4 | Oct 8, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $46 | $26.99 | +70.43% | 26 | Oct 8, 2026 | |
| PEPG PepGen | Reiterated: Buy | $12 | $2.60 | +361.54% | 19 | Oct 8, 2026 | |
| ALKS Alkermes | Reiterated: Buy | $63 | $44.32 | +42.15% | 60 | Oct 5, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $17 | $2.87 | +492.33% | 10 | Oct 5, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $37 | $16.94 | +118.42% | 29 | Sep 30, 2026 | |
| QURE uniQure | Reiterated: Buy | n/a | $24.28 | - | 28 | Sep 29, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Hold | n/a | $521.03 | - | 44 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.01 | - | 30 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $27.54 | +103.34% | 12 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $67 | $37.08 | +80.69% | 8 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.87 | +80.88% | 6 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $30.07 | +43.00% | 1 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $318 | $226.79 | +40.22% | 50 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $55.35 | +26.47% | 47 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $11.81 | +77.82% | 8 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $21.28 | +40.98% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $19.22 | +113.32% | 29 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $38 | $20.02 | +89.81% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 | $20.17 | +23.95% | 51 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $214 → $242 | $252.73 | -4.25% | 52 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $86 → $68 | $43.96 | +54.69% | 33 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $188 → $215 | $146.00 | +47.26% | 55 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.174 | +474.71% | 8 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $92.18 | +44.28% | 12 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $36 | $8.17 | +340.64% | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $0.3681 | +715.00% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $23.19 | +42.30% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.10 | - | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.26 | +342.48% | 9 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.89 | n/a | 11 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $9.57 | n/a | 11 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $3.45 | n/a | 13 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $20 | $79.90 | n/a | 4 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.00001 | n/a | 1 | Aug 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $20 | $0.0001 | n/a | 4 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.25 | n/a | 1 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.07 | n/a | 4 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.0003 | n/a | 3 | May 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $7 | $0.5107 | n/a | 2 | May 6, 2016 |
LB Pharmaceuticals
Oct 21, 2026
Reiterated: Buy
Price Target: $53
Current: $39.64
Upside: +33.70%
Contineum Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $28
Current: $8.99
Upside: +211.46%
Immunic
Oct 8, 2026
Reiterated: Buy
Price Target: $25
Current: $7.61
Upside: +228.52%
Neurogene
Oct 8, 2026
Reiterated: Buy
Price Target: $46
Current: $26.99
Upside: +70.43%
PepGen
Oct 8, 2026
Reiterated: Buy
Price Target: $12
Current: $2.60
Upside: +361.54%
Alkermes
Oct 5, 2026
Reiterated: Buy
Price Target: $63
Current: $44.32
Upside: +42.15%
Lexeo Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $17
Current: $2.87
Upside: +492.33%
Dyne Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $37
Current: $16.94
Upside: +118.42%
uniQure
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.28
Upside: -
Vertex Pharmaceuticals
Sep 22, 2026
Reiterated: Hold
Price Target: n/a
Current: $521.03
Upside: -
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $36.01
Upside: -
Sep 16, 2026
Reiterated: Buy
Price Target: $56
Current: $27.54
Upside: +103.34%
Sep 15, 2026
Reiterated: Buy
Price Target: $60 → $67
Current: $37.08
Upside: +80.69%
Sep 15, 2026
Reiterated: Hold
Price Target: $7
Current: $3.87
Upside: +80.88%
Sep 14, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $30.07
Upside: +43.00%
Aug 31, 2026
Reiterated: Buy
Price Target: $318
Current: $226.79
Upside: +40.22%
Aug 31, 2026
Reiterated: Hold
Price Target: $70
Current: $55.35
Upside: +26.47%
Aug 13, 2026
Reiterated: Buy
Price Target: $21
Current: $11.81
Upside: +77.82%
Aug 13, 2026
Reiterated: Buy
Price Target: $30
Current: $21.28
Upside: +40.98%
Aug 7, 2026
Reiterated: Buy
Price Target: $41
Current: $19.22
Upside: +113.32%
Aug 6, 2026
Reiterated: Buy
Price Target: $32 → $38
Current: $20.02
Upside: +89.81%
Aug 5, 2026
Reiterated: Hold
Price Target: $25
Current: $20.17
Upside: +23.95%
Aug 2, 2026
Reiterated: Buy
Price Target: $214 → $242
Current: $252.73
Upside: -4.25%
Aug 2, 2026
Reiterated: Hold
Price Target: $86 → $68
Current: $43.96
Upside: +54.69%
Jul 31, 2026
Reiterated: Buy
Price Target: $188 → $215
Current: $146.00
Upside: +47.26%
Jul 6, 2026
Reiterated: Hold
Price Target: $1
Current: $0.174
Upside: +474.71%
Jun 15, 2026
Reiterated: Buy
Price Target: $133
Current: $92.18
Upside: +44.28%
Jun 2, 2026
Reiterated: Buy
Price Target: $28 → $36
Current: $8.17
Upside: +340.64%
May 12, 2026
Reiterated: Hold
Price Target: $3
Current: $0.3681
Upside: +715.00%
Apr 2, 2026
Reiterated: Buy
Price Target: $33
Current: $23.19
Upside: +42.30%
Dec 22, 2025
Rated: Hold
Price Target: n/a
Current: $2.10
Upside: -
Dec 16, 2025
Reiterated: Buy
Price Target: $10
Current: $2.26
Upside: +342.48%
Sep 19, 2024
Rated: Hold
Price Target: n/a
Current: $4.89
Upside: n/a
Jun 3, 2023
Reiterated: Buy
Price Target: $5
Current: $9.57
Upside: n/a
May 12, 2022
Reiterated: Hold
Price Target: $3
Current: $3.45
Upside: n/a
Feb 28, 2022
Downgraded: Hold
Price Target: $11 → $20
Current: $79.90
Upside: n/a
Aug 16, 2017
Initiated Coverage: Buy
Price Target: $18
Current: $0.00001
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $14 → $20
Current: $0.0001
Upside: n/a
Nov 23, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.25
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.07
Upside: n/a
May 19, 2016
Reiterated: Buy
Price Target: $11
Current: $0.0003
Upside: n/a
May 6, 2016
Reiterated: Hold
Price Target: $14 → $7
Current: $0.5107
Upside: n/a